Although Astellas sold one pharmaceutical product that uses hydrofluorocarbons (HFCs) as a filler agent, from fiscal 2015 Astellas has not sold any products that emit GHG during use phase because at the end of March 2015 we ceased selling said products in line with our sales strategy concerning related products.
Containers and Packaging Recycling
The products manufactured and marketed by the Company are administered to patients through medical institutions. After their use, packaging materials are disposed of by hospitals, pharmacies, and general households. The waste discarded by general households is mainly comprised of PTP (plastic) packaging used for tablets and capsules. Hospitals and pharmacies discard PTP packaging as well as various types of plastics including bottles and tubes, metals, glass materials used in injectable solutions products, and such paper items as individual packaging and cardboard boxes.
In the case of pharmaceutical packaging, certain functions remain essential to ensure the safe storage of products as well as compliance with the provisions stipulated under the Pharmaceutical and Medical Device Act of Japan. In addition to these functions and requirements, Astellas selects environmentally friendly materials for use in its packaging while engaging in a variety of initiatives including the labeling of materials to promote recycling at the time of disposal.
To encourage the recycling of containers and packaging for household use in Japan, in accordance with the Containers and Packaging Recycling Law (which mandates the sorted collection of containers and packaging, and promotes their reuse in commercial products) sellers of products are responsible for defraying the costs of recycling of such waste products. The estimated total amount of plastic and paper containers and packaging used in Astellas products in fiscal 2019 is 464 tons, and the Company was requested to pay ¥13.89 million in recycling costs.